Total Payments
$161,469
2024 Payments
$71,940
Companies
14
Transactions
112
Medicare Patients
9,338
Medicare Billing
$205,155
Payment Breakdown by Category
Consulting$145,067 (89.8%)
Research$12,297 (7.6%)
Other$1,786 (1.1%)
Travel$1,709 (1.1%)
Food & Beverage$609.90 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $145,067 | 70 | 89.8% |
| Unspecified | $12,297 | 16 | 7.6% |
| Grant | $1,786 | 1 | 1.1% |
| Travel and Lodging | $1,709 | 13 | 1.1% |
| Food and Beverage | $609.90 | 12 | 0.4% |
Payments by Type
General
$149,172
96 transactions
Research
$12,297
16 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $85,213 | 24 | $0 (2024) |
| Cook Research Incorporated | $25,273 | 39 | $0 (2020) |
| JAZZ PHARMACEUTICALS INC. | $17,025 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $11,750 | 6 | $0 (2024) |
| PFIZER INC. | $11,021 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $6,500 | 1 | $0 (2021) |
| Acorda Therapeutics, Inc | $3,400 | 3 | $0 (2017) |
| Theravance Biopharma Inc. | $600.00 | 2 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $350.00 | 1 | $0 (2022) |
| Medtronic, Inc. | $203.58 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71,940 | 22 | Eli Lilly and Company ($49,700) |
| 2023 | $10,306 | 5 | PFIZER INC. ($6,746) |
| 2022 | $553.58 | 8 | Ipsen Biopharmaceuticals, Inc ($350.00) |
| 2021 | $14,546 | 5 | Eli Lilly and Company ($7,950) |
| 2020 | $6,667 | 12 | Cook Research Incorporated ($4,767) |
| 2019 | $11,970 | 17 | Cook Research Incorporated ($8,159) |
| 2018 | $21,913 | 24 | Cook Research Incorporated ($11,947) |
| 2017 | $23,573 | 19 | Eli Lilly and Company ($17,238) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $120.60 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $120.60 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $55.18 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $48.06 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $36.31 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $9,576.00 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $392.12 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $72.64 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $64.70 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $39.00 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $1,368.00 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $146.95 | General |
| Category: NEUROLOGY | ||||||
| 08/16/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $11,200.00 | General |
| 08/09/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 06/13/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 05/03/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $35,000.00 | General |
| 04/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: NEUROLOGY | ||||||
| 04/11/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 01/25/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 09/23/2023 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $60.60 | General |
| 09/14/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 06/28/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Cook IVC Filter Post-Market Study | Cook Research Incorporated | $11,947 | 15 |
| A Phase 2, Two-part, Placebo-controlled, Parallel-group, Double-blind Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva in Male and Female Participants 5 Years of Age and Older. | Ipsen Biopharmaceuticals, Inc | $350.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,104 | 2,567 | $179,805 | $43,944 |
| 2022 | 12 | 2,089 | 2,496 | $187,188 | $45,214 |
| 2021 | 17 | 2,780 | 3,428 | $258,807 | $65,655 |
| 2020 | 14 | 2,365 | 2,863 | $205,637 | $50,342 |
Total Patients
9,338
Total Services
11,354
Medicare Billing
$205,155
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 118 | $25,488 | $9,664 | 37.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 184 | 185 | $29,230 | $9,146 | 31.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,235 | 1,633 | $68,700 | $9,054 | 13.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 94 | $14,664 | $5,263 | 35.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 30 | $6,510 | $2,664 | 40.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 272 | 293 | $14,650 | $2,634 | 18.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,174 | $2,143 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,069 | $1,027 | 25.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $2,936 | $880.33 | 30.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 77 | 78 | $1,560 | $471.26 | 30.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 23 | 23 | $1,242 | $319.00 | 25.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $756.00 | $238.78 | 31.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $678.00 | $171.71 | 25.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 14 | 14 | $1,008 | $126.24 | 12.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 13 | 13 | $390.00 | $111.80 | 28.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 15 | 15 | $750.00 | $28.08 | 3.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 243 | 250 | $39,500 | $12,258 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 131 | $28,296 | $10,924 | 38.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,235 | 1,542 | $71,929 | $8,868 | 12.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 74 | $11,544 | $4,196 | 36.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 308 | 349 | $17,450 | $3,111 | 17.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 30 | $6,510 | $2,224 | 34.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,064 | $1,774 | 35.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 15 | $2,280 | $798.75 | 35.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 34 | 34 | $1,836 | $559.02 | 30.4% |
About Dr. Richard Kovacs, MD
Dr. Richard Kovacs, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447215777.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Kovacs, MD has received a total of $161,469 in payments from pharmaceutical and medical device companies, with $71,940 received in 2024. These payments were reported across 112 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($145,067).
As a Medicare-enrolled provider, Kovacs has provided services to 9,338 Medicare beneficiaries, totaling 11,354 services with total Medicare billing of $205,155. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Critical Care Medicine, Cardiovascular Disease
- Location Indianapolis, IN
- Active Since 04/19/2006
- Last Updated 09/23/2025
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1447215777
Products in Payments
- XYWAV (Drug) $13,990
- ELIQUIS (Drug) $6,500
- VYNDAQEL (Drug) $4,275
- SUNOSI (Drug) $1,050
- LEQVIO (Drug) $96.34
- GENERAL STENTS (Device) $16.07
- XYOSTED (Drug) $11.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Indianapolis
Joseph Szwed, Md, MD
Clinical Cardiac Electrophysiology — Payments: $139,319
Clinical Cardiac Electrophysiology $139,319
Jothiharan Mahenthiran, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $104,207
Clinical Cardiac Electrophysiology $104,207
Dr. Sharath Vipparthy, Md, MD
Clinical Cardiac Electrophysiology — Payments: $93,176
Clinical Cardiac Electrophysiology $93,176
Dr. Christopher Reed, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $75,279
Clinical Cardiac Electrophysiology $75,279
David Wrobleski, Md, MD
Clinical Cardiac Electrophysiology — Payments: $12,816
Clinical Cardiac Electrophysiology $12,816
Nektarios Vasilottos, Md, MD
Clinical Cardiac Electrophysiology — Payments: $10,866
Clinical Cardiac Electrophysiology $10,866